This study also established involvement of CCL24 in fibroblast and endothelial cell activation, which are known to participate in IPF pathogenesis, as well as the broad applicability of CM-101 in strategies for inhibiting these activities. This evidence concerns the gene CCL24 and idiopathic pulmonary fibrosis.